Dr. Reddy's Laboratories

NYSE
RDY
Stock
Yield per half year: +4.59%
Dividend yield: 2.72%
Sector: Healthcare

Reporting Dr. Reddy's Laboratories

Reports

2016 2017 2018 2019 2022 2023 2024
Financial report link link link link link link link


Capitalization

2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Average for 5 years CAGR 5
Capitalization, bln ₹
6.47 5.61 6.38 9.15 10.97 9.08 10.3 12 205 088.14 12.16 12.16
Revenue, bln ₹
140.81 142.03 153.85 174.6 189.72 214.39 245.88 279.16 325.54 325.54
Net profit, bln ₹
12.04 9.81 18.8 19.5 17.24 23.57 45.07 55.68 56.54 56.54
EV, bln ₹
36.92 53.06 41.98 633.99 26.45 160.64 786.3 1 032.91 972.55 972.55
EBIT, bln ₹
13.5 11.92 23.61 49.53 36.06 35.92 61.8 73.58 79.61 79.61
EBITDA, bln ₹
24.78 23.63 23.61 49.53 48.86 47.74 74.43 88.42 96.67 96.67
OIBDA, bln ₹
26.23 25.74 25.7 59.34 64.53 64.99 125.65 100.47 111.97 111.97
Book value, bln ₹
124.04 126.46 140.2 154.99 174.98 190.53 232.86 280.55 333.39 333.39
FCF, bln ₹
-19.47 6.99 21.21 23.73 23.14 9.06 40.01 18 12.03 12.03
Operating Cash Flow, bln ₹
21.51 18.03 28.7 29.84 35.7 28.11 58.87 45.43 46.43 46.43
Operating profit, bln ₹
13.5 11.92 20.89 37.06 36.06 40.82 96.28 67.73 71.84 71.84
Operating expenses, bln ₹
64.86 64.39 62.54 61.25 70.12 76.8 117.62 95.88 118.59 118.59
CAPEX, bln ₹
40.98 11.04 7.49 6.12 12.56 19.05 18.86 27.44 34.4 34.4


Balance sheet

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Average for 5 years CAGR 5
Cash, bln ₹
18.14 2.64 2.23 2.05 14.83 14.85 5.78 7.11 14.65 14.65
Short-Term Investments ₹
14.27 18.33 22.53 23.69 19.74 29.51 60.97 74.36 43.25 43.25
Long-Term Investments ₹
0.806 0 6.84 4.65 3.34 3.09 8.33 7.99 6.09
Accounts Receivable ₹
49.15 45.18 43.27 61.75 52.39 66.76 72.49 95.34 109.79 109.79
Total Current Assets ₹
100.38 109.65 114.5 130.37 148.25 181.11 204.26 248.05 250.11 250.11
Net assets, bln ₹
57.16 57.87 54.09 52.33 57.11 62.17 232.86 280.55 333.39 333.39
Assets, bln ₹
219.82 225.6 225.43 232.24 265.49 296.65 322.85 387.52 492.99 492.99
Short-Term Debt ₹
43.74 25.63 16.38 20.8 24.01 28.1 12.19 14.03 38.9 38.9
Long-Term Debt ₹
4.85 24.46 21.45 0.0158 6.3 5.75 1.28 5.99 7.86 7.86
Liabilities, bln ₹
95.78 99.14 85.23 77.25 90.51 106.13 89.99 106.97 155.82 155.82
Net debt, bln ₹
31.05 48.08 36.15 20.05 15.48 18.99 7.69 12.91 32.11 32.11
Debt, bln ₹
48.59 50.08 37.83 26.2 30.31 33.85 13.47 20.02 46.77 46.77
Interest Income ₹
2.48 1.16 2.42 1.56 2.03 1.65 3.08 1.06
Interest Expense, bln ₹
0.634 0.788 1.16 0.983 0.97 0.958 1.43 1.71 2.83 2.83
Net interest income, bln ₹
1.65 -0.076 -0.248 -0.119 -0.09 1.65 2.12 -1.43 0.0272 0.0126
Goodwill ₹
3.43 3.38 3.85 3.75 3.95 3.9 3.99 4.57 4.42 5.47
Amortization, bln ₹
11.28 11.71 0.000172 0.000206 12.8 11.82 12.64 14.84 17.06 17.06
Cost of production, bln ₹
62.45 65.72 70.42 80.59 86.65 100.55 42.91 115.56 135.11 135.11
Inventory ₹
28.53 29.09 33.58 35.07 45.41 50.88 48.67 63.55 71.09 71.09


Share

2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Average for 5 years CAGR 5
EPS 19.55 46.71 1.59 2.76 1.56 141.69 54.17 66.8 67.77 67.77
Share price 37.56 37.7 40.58 71.29 65.41 51.75 13.92 15.79 14.58 14.58
Number of shares, mln 166.12 166.11 165.76 166.39 166.31 166.34 831.91 833.54 834.3 834.3
FCF/share -117.21 42.06 127.98 142.6 139.15 54.46 48.09 21.59 14.42 14.42


Efficiency

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average Average for 5 years CAGR 5
ROE, % 9.71 7.75 13.41 12.58 9.85 12.9 19.35 19.85 16.96 16.96 6.42
ROA, % 5.48 4.35 8.34 8.4 6.49 8.39 13.96 14.37 11.47 11.47 7.41
ROIC, % 14.97 8.94 7.82 12.81 11 10.42 12.72 20.99 20.74 20.74 16.26
ROS, % 8.55 6.9 12.22 11.17 9.09 10.99 18.33 19.95 17.37 17.37 11.41
ROCE, % 10.88 9.42 16.84 31.96 20.61 18.07 26.54 26.23 23.61 23.61 92.14
EBIT margin 9.59 8.39 15.34 28.37 17.35 16.75 25.13 26.36 24.46 24.46 15.72
EBITDA margin 17.59 16.64 15.34 28.37 25.75 22.27 30.27 31.67 29.7 29.7 22.49
Net margin 8.55 6.9 12.22 11.17 9.09 10.99 18.33 19.95 17.37 17.37 13.20
Operational efficiency, % 9.59 8.39 13.58 21.22 19.01 19.04 39.16 24.26 22.07 22.07 16.24
Net interest margin, % 14.43 16.28 14.97 12.94 8.55 6.9 12.22 11.17 9.09 12.69 16.78
FCF yield, % -301.05 124.53 332.46 259.32 210.97 99.82 388.48 0.000147 98.9 98.9 6.90


Coefficients

2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average Average for 5 years CAGR 5
P/E
0.5372 0.5721 0.3395 0.4692 0.6363 6.01 17.28 18.33 0.2151 0.2151 29.64
P/BV
0.0521 0.0444 0.0455 0.059 0.0627 0.7435 3.34 3.64 0.0365 0.0365 13.73
P/S
0.0459 0.0395 0.0415 0.0524 0.0578 0.6607 3.17 3.66 0.0374 0.0374 4.30
P/FCF
-0.3322 0.803 0.3008 0.3856 0.474 1 0.2574 0.6534 1.01 1.01 72.81
E/P
1.86 1.75 2.95 2.13 1.57 2.6 4.38 4.74 4.65 4.65 0.05
EV/EBIT
2.74 4.45 1.78 2.49 5.08 4.47 12.72 14.04 12.22 12.22 21.61
EV/EBITDA
1.49 2.25 1.78 10.8 0.5413 3.36 10.56 11.68 10.06 10.06 19.21
EV/S
0.2622 0.3736 0.2729 3.07 0.1394 0.7493 3.2 3.7 2.99 2.99 4.48
EV/FCF
-1.9 7.59 1.98 22.56 1.14 17.73 19.65 57.39 80.84 80.84 90.50
Debt/EBITDA
1.96 2.12 1.6 0.4463 0.6203 0.7089 0.181 0.2264 0.4838 0.4838 3.24
Netdebt/EBITDA
1.25 2.03 1.53 0.4048 0.3168 0.3978 0.1034 0.146 0.3322 0.3322 2.63
Debt/Ratio
0.221 0.222 0.1678 0.33 0.1142 0.1141 0.0417 0.0517 0.0949 0.0949 0.30
Debt/Equity
0.3917 0.396 0.2698 0.5 0.1732 0.1776 0.0579 0.0714 0.4622 0.4622 6.68
Debt/Net Income
4.04 5.11 2.01 1.13 1.76 1.44 0.2989 0.3595 0.8271 0.8271 4.64
PEG
3.7E-5 3.7E-5 45.17
Beta
-0.03 0.12 0.24 -0.4885 1.39 -0.1417 -0.1417 0.74
Altman Index
2.23 1.79 2.08 3.19 3.68 3.42 7.28 4.24 7.39 7.39 3.89


Dividends

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average Average for 5 years CAGR 5
Dividend payout, bln
4.11 3.39 3.99 4 3.92 4.15 4.98 6.65 6.66 6.66
Dividend
0.3139 0.292 0.2822 0.3334 0.342 0.765 0.1941 0.886 0.0915 0.0915
Dividend yield, %
0.8063 0.8646 0.7332 0.6062 0.5185 7.91 0.7137 0.6184 2.72 2.72 2.08
Dividends / profit, %
28.16 40.71 21.29 20.08 24.06 17.59 11.05 11.94 11.78 11.78 51.87
Dividend coverage ratio
3.55 2.46 4.7 4.98 4.16 4.73 6.78 8.36 8.49 8.49 5.26


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Other

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM CAGR 5
CAPEX/Revenue, %
29.11 7.78 4.87 3.5 6.62 8.89 7.67 9.83 10.57 10.57
R&D, bln
301 000 281 000 226 000 15 410 000 15 410 000 16 541 000 17 482 000 19 381 000 22 873 000 18 341 000
Total Debt
69.69 59.7 72.81 83.39 83.39
Staff, people
22 739 22 739 24 795 25 863